Newsroom
Sorted by: Latest
-
Kennedy Wilson Announces Launch of Tender Offer for Any and All of Its Outstanding 5.000% Senior Notes Due 2031 and Issuance of Notices of Redemption for its 4.750% Senior Notes Due 2029 and its 4.750% Senior Notes Due 2030
BEVERLY HILLS, Calif.--(BUSINESS WIRE)--Kennedy-Wilson, Inc. (the “Issuer”), a wholly-owned subsidiary of global real estate investment company Kennedy-Wilson Holdings, Inc. (NYSE: KW) (the “Company” or “Kennedy Wilson”), today announced that it has commenced an offer to purchase for cash (the “Offer”) any and all of its outstanding 5.000% Senior Notes due 2031 (the “Notes”), upon the terms and subject to the conditions set forth in the Offer to Purchase, dated May 15, 2026, as it may be amende...
-
Sugar Foods Issues Recall of Specific Lots of Kroger Homestyle Cheese Garlic Croutons Due to Possible Health Risk
WESTLAKE VILLAGE, Calif.--(BUSINESS WIRE)--Sugar Foods LLC is recalling certain lots of Kroger Homestyle Cheese Garlic Croutons, 5oz pouches, UPC 0 11110 81353 4 due to the potential for Salmonella contamination associated with milk powder used as an ingredient in the product. Salmonella is an organism that can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy persons infected with Salmonella may experience...
-
Retractable Technologies, Inc. Results for the Period Ended March 31, 2026
LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) reports total net sales of $7.2 million for the first three months of 2026 and an operating loss of $6.2 million for the period, as compared to total net sales for the same period last year of $8.3 million and an operating loss of $4.7 million. In the first quarter of 2026, a larger proportion of international sales and an increase in EasyPoint® needle sales contributed to lower overall revenues despite unit...
-
Driven Brands Holdings Inc. to Host 2025 Fourth Quarter and Year-End Earnings Call on May 19, 2026
CHARLOTTE, N.C.--(BUSINESS WIRE)--Driven Brands Holdings Inc. (NASDAQ: DRVN) (“Driven Brands” or the “Company”) will release its financial results for the fourth quarter and fiscal year ended December 27, 2025, before the market opens on May 19, 2026. Following the release, management will host a conference call at 8:30 a.m. ET to review the Company’s financial and operating performance. The call will be available by webcast and can be accessed by visiting the Company’s Investor Relations websi...
-
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK; the “Company”) today announced that the company granted inducement equity awards covering an aggregate of 38,481 shares of its common stock to six newly hired employees, consisting of inducement stock options to purchase an aggregate of 12,061 shares of common stock and inducement restricted stock units, covering an aggregate of 26,420 shares of its common stock. The awards are subject to all terms and conditions and other provision...
-
Westlake Corporation Declares Quarterly Dividend
HOUSTON--(BUSINESS WIRE)--The Board of Directors of Westlake Corporation (NYSE: WLK) today declared a regular dividend distribution of $0.53 per share for the first quarter of 2026. This dividend will be payable on June 11, 2026 to stockholders of record on May 27, 2026. Westlake announced its first dividend on November 11, 2004 and has successively been paying and increasing its dividend for the past 22 years. The statements in this release that are not historical facts, including statements r...
-
MetLife Declares Second Quarter 2026 Preferred Stock Dividends
NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) today announced that it has declared the following preferred stock dividends: Quarterly dividend of $0.31190376 per share on the company’s floating rate non-cumulative preferred stock, Series A, with a liquidation preference of $25 per share (NYSE: MET PRA). Quarterly dividend of $351.5625 per share on the company’s 5.625% non-cumulative preferred stock, Series E, with a liquidation preference of $25,000 per share, represented by depositary s...
-
Xylem Declares Second Quarter Dividend of 43 Cents per Share
WASHINGTON--(BUSINESS WIRE)--The Board of Directors of Xylem Inc. (NYSE: XYL), has declared a second quarter dividend of $0.43 per share payable on June 25, 2026, to shareholders on record as of May 28, 2026. About Xylem Xylem (XYL) is a Fortune 500 global water solutions company that empowers customers and communities to build a more water-secure world. Our 22,000 employees delivered revenue of $9 billion in 2025, optimizing water and resource management with innovation and expertise. Join us...
-
Rayonier Announces Second Quarter 2026 Dividend
WILDLIGHT, Fla.--(BUSINESS WIRE)--Rayonier Inc. (NYSE:RYN) announced today that the Company’s board of directors has declared a second quarter cash dividend of $0.26 per common share. The dividend is payable on June 30, 2026, to shareholders of record on June 16, 2026. The Company also announced today that the Company’s board of directors, in its capacity as the board of directors of the general partner of Rayonier, L.P., has declared a second quarter cash distribution of $0.26 per operating pa...
-
Agenus Announces Publication of Phase 1b Botensilimab and Balstilimab Data in Post-Immunotherapy Hepatocellular Carcinoma in Liver Cancer
LEXINGTON, Mass.--(BUSINESS WIRE)--Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced the publication of Phase 1b data evaluating botensilimab (BOT), an Fc-enhanced anti-CTLA-4 antibody, in combination with balstilimab (BAL), an anti-PD-1 antibody, in patients with treatment-refractory hepatocellular carcinoma (HCC) who had progressed following prior immunotherapy. The manuscript, titled “A phase 1b study of botensilimab and balstilimab in treatment-refractory h...